Laboratory analysis reveals nano chitosan-paracetamol reduces infected colon cancer cells in HCT-29, suggesting potential as an anti-cancer treatment.
One of the gastrointestinal system's most frequent malignant maximums is colon cancer. Currently, surgical resection is the main course of treatment. Nevertheless, colon cancer is prone to metastasis and recurrence, making the development of an efficient anti-cancer medication imperative. The present investigation employed FT-IR and 1HNMR technique’s to characterization of the synthesis and examination of nano Chitosan-Paracetemol composites. The cytotoxic potential of the new medicine (Nano Chitosan-Paracetemol composites) was evaluated, which had excellent results in our study, the number of infected cells decreased to (IC50=71.26 µg/ml). This work aimed to validate the cytotoxicity of nano Chitosan-Paracetemol on the colon cancer cell line HCT-29 as well as the efficacy of its reduction of metastasis of colon cancer.
No takes yet. Share an insight, caveat, or question.
Abdulnabi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: